These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22982909)

  • 1. Rituximab in treatment of idiopathic glomerulopathy.
    El-Reshaid K; Sallam HT; Hakim AA; Al-Attiyah R
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):973-8. PubMed ID: 22982909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
    Basu B; Mahapatra TK; Mondal N
    Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
    Ravani P; Ponticelli A; Siciliano C; Fornoni A; Magnasco A; Sica F; Bodria M; Caridi G; Wei C; Belingheri M; Ghio L; Merscher-Gomez S; Edefonti A; Pasini A; Montini G; Murtas C; Wang X; Muruve D; Vaglio A; Martorana D; Pani A; Scolari F; Reiser J; Ghiggeri GM
    Kidney Int; 2013 Nov; 84(5):1025-33. PubMed ID: 23739238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
    Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K; El-Reshaid W; Madda J
    Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.
    Ravani P; Magnasco A; Edefonti A; Murer L; Rossi R; Ghio L; Benetti E; Scozzola F; Pasini A; Dallera N; Sica F; Belingheri M; Scolari F; Ghiggeri GM
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1308-15. PubMed ID: 21566104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
    Huang J; Du J; Wang S; Xiao L; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Rituximab Therapy in Adult Patients with Idiopathic Nephrotic Syndrome.
    El-Reshaid K; Al-Bader S; Madda JP
    Saudi J Kidney Dis Transpl; 2022; 33(4):509-515. PubMed ID: 37929543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofatumumab for rituximab-resistant nephrotic syndrome.
    Basu B
    N Engl J Med; 2014 Mar; 370(13):1268-70. PubMed ID: 24670185
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of rituximab treatment in children with primary glomerulonephritis.
    Zachwieja J; Silska M; Ostalska-Nowicka D; Soltysiak J; Lipkowska K; Blumczynski A; Musielak A
    J Nephrol; 2012; 25(6):1060-6. PubMed ID: 22322817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
    Nickavar A; Safarzadeh AE; Sotoudeh K; Otukesh H; Hooman N
    Iran J Kidney Dis; 2012 Sep; 6(5):346-9. PubMed ID: 22976259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P; Panczyk-Tomaszewska M; Roszkowska-Blaim M; Wawer Z; Bienias B; Zajgzkowska M; Kilis-Pstrusinska K; Jakubowska A; Szczepaniak M; Pawlak-Bratkowska M; Tkaczyk M
    Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in children with resistant idiopathic nephrotic syndrome.
    Magnasco A; Ravani P; Edefonti A; Murer L; Ghio L; Belingheri M; Benetti E; Murtas C; Messina G; Massella L; Porcellini MG; Montagna M; Regazzi M; Scolari F; Ghiggeri GM
    J Am Soc Nephrol; 2012 Jun; 23(6):1117-24. PubMed ID: 22581994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of FSGS in Children.
    Sethna CB; Gipson DS
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):194-9. PubMed ID: 24602468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.
    Marasà M; Cravedi P; Ruggiero B; Ruggenenti P
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25155494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in the treatment of nephrotic syndrome: a systematic review.
    Otukesh H; Hoseini R; Rahimzadeh N; Fazel M
    Iran J Kidney Dis; 2013 Jul; 7(4):249-56. PubMed ID: 23880800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
    Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
    Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
    Kemper MJ; Valentin L; van Husen M
    Pediatr Nephrol; 2018 Oct; 33(10):1641-1649. PubMed ID: 28879428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
    Ravani P; Bonanni A; Ghiggeri GM
    BMJ Open; 2017 Mar; 7(3):e013319. PubMed ID: 28314744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.